Detalhe da pesquisa
1.
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Nature
; 615(7953): 678-686, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922586
2.
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
PLoS Pathog
; 13(8): e1006487, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771605
3.
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.
J Infect Dis
; 207(5): 700-8, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225894
4.
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
mSphere
; 5(1)2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969476
5.
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques.
PLoS Negl Trop Dis
; 14(4): e0008191, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267846
6.
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
Hum Vaccin
; 5(1): 33-40, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18670195
7.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.
Am J Trop Med Hyg
; 78(3): 426-33, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18337339
8.
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial.
Am J Trop Med Hyg
; 93(3): 454-460, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149862
9.
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques.
Am J Trop Med Hyg
; 92(4): 698-708, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646261
10.
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.
Am J Trop Med Hyg
; 69(6 Suppl): 24-31, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14740952
11.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.
Am J Trop Med Hyg
; 85(2): 341-51, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813857
12.
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.
Vaccine
; 28(15): 2705-15, 2010 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20097152
13.
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
Am J Trop Med Hyg
; 79(1): 115-22, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606774
14.
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
J Infect Dis
; 193(12): 1658-65, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16703509